Full history for every metric is available with a Kvantra account
ETAO International Co., Ltd. (ETAO)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | - | - | 53 | 58 | 58 |
| Operating profit | $m | -737 | -737 | |||||
| Net profit | $m | - | - | - | - | -11 | -897 | -897 |
| EPS reported | $ | -169.6 | -0.60 | |||||
| Operating cashflow per share | $ | 2.05 | 2.05 | |||||
| Capex per share | $ | 0.12 | 0.12 | |||||
| FCF per share | $ | 1.93 | 1.93 | |||||
| Free cash flow | $m | 10 | 11 | |||||
| Net debt | $m | -6 | 1 | |||||
| Book value equity | $m | -16 | - | |||||
| Book value per share | $ | -2.95 | - | |||||
| Number of shares | m | 5.29 | - | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -68.65 | -0.65 | |||||
| P/S LTM | x | 18.44 | 0.17 | |||||
| P/FCF LTM | x | 105.09 | 0.90 | |||||
| EV/EBITDA LTM | x | -1.21 | -0.01 | |||||
| EV/Sales LTM | x | 18.56 | 0.18 | |||||
| Earnings Yield LTM | % | -83.73% | -8881.9% | |||||
| FCF Yield | % | 0.95% | 111.23% | |||||
| Quality | ||||||||
| ROE | % | 5748.4% | -1369.5% | |||||
| ROIC | % | -2576.7% | -2576.7% | |||||
| Operating margin | % | -1269.6% | -1269.6% | |||||
| Gross margin | % | 32.72% | 32.72% | |||||
| FCF/Sales | % | 17.55% | 17.55% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +8.85% | +8.85% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.66 | 5.80 | |||||
| Net Debt/EBITDA | x | -0.01 | -0.01 | |||||
| EBIT/Net interest | x | -1,463.41 | -1,463.41 | |||||
| Net debt/market cap | % | -0.58% | 7.00% | |||||
| Net debt/Equity | x | 0.40 | - | |||||
| Gross debt/equity | x | -0.99 | - | |||||
Company overview
ETAO International Co., Ltd., headquartered in New York, is a digital healthcare firm specializing in providing medical services and advanced biomedical technologies to patients throughout China. The company is actively constructing an expansive healthcare ecosystem. This comprehensive network is designed to integrate hospitals, specialized clinics, artificial intelligence and big data-powered diagnostic tools, medical analysis services, biotechnology companies, and an insurance agency, all aimed at ensuring patients have seamless access to medical assistance and a broad spectrum of healthcare services.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
ETAO International Co., Ltd. (ETAO)
ETAO International Co., Ltd., headquartered in New York, is a digital healthcare firm specializing in providing medical services and advanced biomedical technologies to patients throughout China. The company is actively constructing an expansive healthcare ecosystem. This comprehensive network is designed to integrate hospitals, specialized clinics, artificial intelligence and big data-powered diagnostic tools, medical analysis services, biotechnology companies, and an insurance agency, all aimed at ensuring patients have seamless access to medical assistance and a broad spectrum of healthcare services.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free